| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |